CHEBI:107425 - 2-[(4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methylamino]-5-ethyl-3-thiophenecarboxylic acid ethyl ester

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name 2-[(4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methylamino]-5-ethyl-3-thiophenecarboxylic acid ethyl ester
ChEBI ID CHEBI:107425
Stars This entity has been manually annotated by a third party.
Supplier Information
Download Molfile XML SDF
Formula C14H15N3O4S2
Net Charge 0
Average Mass 353.419
Monoisotopic Mass 353.05040
InChI InChI=1S/C14H15N3O4S2/c1-3-7-5-8(13(20)21-4-2)12(23-7)15-6-9-10(18)16-14(22)17-11(9)19/h5-6,15H,3-4H2,1-2H3,(H2,16,17,18,19,22)
InChIKey MRAINDNXXUSXSU-UHFFFAOYSA-N
SMILES CCC1=CC(=C(S1)NC=C2C(=O)NC(=S)NC2=O)C(=O)OCC
Roles Classification
Biological Role(s): GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
Application(s): GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing 2-[(4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methylamino]-5-ethyl-3-thiophenecarboxylic acid ethyl ester (CHEBI:107425) is a barbiturates (CHEBI:22693)
Manual Xref Database
LSM-18779 LINCS
View more database links